These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17650517)

  • 41. Antiplatelet therapy and outcome in patients undergoing surgery following coronary stenting: Results of the surgery after stenting registry.
    Rossini R; Angiolillo DJ; Musumeci G; Capodanno D; Lettino M; Trabattoni D; Pilleri A; Calabria P; Colombo P; Bernabò P; Ferlini M; Ferri M; Tarantini G; De Servi S; Savonitto S
    Catheter Cardiovasc Interv; 2017 Jan; 89(1):E13-E25. PubMed ID: 27404797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coronary artery stenting and non-cardiac surgery--a prospective outcome study.
    Vicenzi MN; Meislitzer T; Heitzinger B; Halaj M; Fleisher LA; Metzler H
    Br J Anaesth; 2006 Jun; 96(6):686-93. PubMed ID: 16670113
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute myocardial infarction related to very late sirolimus-eluting stent thrombosis 6 months after discontinuation of dual antiplatelet therapy.
    Balbi M; Fedele M; Bezante GP; Brunelli C; Barsotti A
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):839-42. PubMed ID: 20216229
    [No Abstract]   [Full Text] [Related]  

  • 45. New oral anticoagulants and perioperative management of anticoagulant/antiplatelet agents.
    Rahman A; Latona J
    Aust Fam Physician; 2014 Dec; 43(12):861-6. PubMed ID: 25705736
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery. Results of a multicentre registry.
    Rossini R; Musumeci G; Capodanno D; Lettieri C; Limbruno U; Tarantini G; Russo N; Calabria P; Romano M; Inashvili A; Sirbu V; Guagliumi G; Valsecchi O; Senni M; Gavazzi A; Angiolillo DJ
    Thromb Haemost; 2015 Feb; 113(2):272-82. PubMed ID: 25274620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perioperative management of patient with intracoronary stent presenting for noncardiac surgery.
    Gurajala I; Gopinath R
    Ann Card Anaesth; 2016; 19(1):122-31. PubMed ID: 26750683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of six versus 12 months of dual antiplatelet therapy in patients with drug-eluting stent implantation after risk stratification with the residual SYNTAX score: Results from a secondary analysis of the I-LOVE-IT 2 trial.
    Qiu M; Li Y; Li J; Xu K; Jing Q; Dong S; Jin Z; Zhao P; Xu B; Han Y
    Catheter Cardiovasc Interv; 2017 Mar; 89(S1):565-573. PubMed ID: 28211603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiplatelet therapy in ENT surgery: a review.
    Sylvester DC; Coatesworth AP
    J Laryngol Otol; 2012 Apr; 126(4):331-6. PubMed ID: 22182587
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety and efficacy of 6-month versus 12-month dual antiplatelet therapy in patients after implantation of multiple biodegradable polymer-coated sirolimus-eluting coronary stents: Insight from the I-LOVE-IT 2 trial.
    Qi J; Li Y; Li J; Jing Q; Xu K; Gao C; Ma L; Zhang Z; Xu B; Han Y
    Catheter Cardiovasc Interv; 2017 Mar; 89(S1):555-564. PubMed ID: 28318138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intraoperative thrombosis of right coronary artery drug-eluting stent after 2 years of dual antiplatelet therapy.
    Murray AT; Sederberg JH
    Semin Cardiothorac Vasc Anesth; 2011; 15(1-2):40-3. PubMed ID: 21840879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Shorter (≤6 months) versus longer (≥12 months) duration dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomized clinical trials.
    Pandit A; Giri S; Hakim FA; Fortuin FD
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):34-40. PubMed ID: 24753084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The state of periprocedural antiplatelet therapy after recent trials.
    Desai NR; Bhatt DL
    JACC Cardiovasc Interv; 2010 Jun; 3(6):571-83. PubMed ID: 20630450
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coronary artery stents and non-cardiac surgery.
    Howard-Alpe GM; de Bono J; Hudsmith L; Orr WP; Foex P; Sear JW
    Br J Anaesth; 2007 May; 98(5):560-74. PubMed ID: 17456488
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation.
    Yan BP; Gurvitch R; Ajani AE
    Cardiovasc Revasc Med; 2006; 7(3):155-8. PubMed ID: 16945822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Late coronary thrombosis in paclitaxel-eluting stents. Case reports.
    Cassin M; De Biasio M; Macor F; Burelli C; Vendrametto F; Driussi M; Nicolosi GL
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):284-8. PubMed ID: 17413307
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Perioperative Management of Lung Cancer Patients with atrial fibrillation being treated by antiplatelet or anticoagulant therapy].
    Ishikawa S; Kasai Y; Matsuura N; Tarumi S; Nakano J; Okuda M; Goto M; Ryu D; Go T; Yokomise H
    Kyobu Geka; 2015 Apr; 68(4):262-5. PubMed ID: 25836998
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2.
    Tada T; Natsuaki M; Morimoto T; Furukawa Y; Nakagawa Y; Byrne RA; Kastrati A; Kadota K; Iwabuchi M; Shizuta S; Tazaki J; Shiomi H; Abe M; Ehara N; Mizoguchi T; Mitsuoka H; Inada T; Araki M; Kaburagi S; Taniguchi R; Eizawa H; Nakano A; Suwa S; Takizawa A; Nohara R; Fujiwara H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T;
    Circ Cardiovasc Interv; 2012 Jun; 5(3):381-91. PubMed ID: 22619260
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Perioperative management of a neurosurgical patient with a meningioma and recent coronary artery stent.
    Rouine-Rapp K; McDermott MW
    J Clin Anesth; 2013 May; 25(3):228-31. PubMed ID: 23688961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Perioperative Cardiovascular Medication Management in Noncardiac Surgery: Common Questions.
    Mikhail MA; Mohabbat AB; Ghosh AK
    Am Fam Physician; 2017 May; 95(10):645-650. PubMed ID: 28671407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.